Volociximab

**Semantic type:** Amino Acid, Peptide, or Protein|Immunologic Factor|Pharmacologic Substance

**Definition:** A chimeric monoclonal antibody with potential antineoplastic activity. Volociximab binds to and inhibits the activity of alpha(5)beta(1) integrin, thereby inhibiting endothelial cell-cell interactions, endothelial cell-matrix interactions, and angiogenesis. (NCI05)

**Synonyms:** - Anti-alpha5-beta1 Integrin - M200 - M200 - VOLOCIXIMAB - anti-a5-beta1 Integrin - volociximab